Data completeness
1/8 — Limited
EMTRICITABINE; TENOFOVIR ALAFENAMIDE by Aurobindo Pharma is fixed-dose combination of antiretroviral drugs darunavir (plus the cyp3a inhibitor cobicistat), emtricitabine, and tenofovir alafenamide [see ] .
Drug data last refreshed 22h ago
Mechanism of Action
fixed-dose combination of antiretroviral drugs darunavir (plus the CYP3A inhibitor cobicistat), emtricitabine, and tenofovir alafenamide [see ] .
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on EMTRICITABINE; TENOFOVIR ALAFENAMIDE at Aurobindo Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.